Analysts' Actions: CHK, JNJ, BIIB, CNO, UNH

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Chase ( CCF) downgraded to hold at TheStreet Ratings.

Chesapeake Energy ( CHK) downgraded at Bernstein from Outperform to Market Perform, Bernstein Research said. $21 price target. Company lacks near-term catalysts.

Majesco Entertainment ( COOL) downgraded to hold at TheStreet Ratings.

E*Trade ( ETFC) upgraded at BGB from Sell to Hold, BGB Securities said. Valuation call, based on a $7.50 price target.

Fortinet ( FTNT) upgraded at UBS to Buy from Neutral, UBS said. $28 price target. Upside to street estimates on increasing market share.

Genon Energy ( GEN) upgraded at UBS to Neutral from Sell, UBS said. $1.50 price target. Shares fairly valued.

Hill-Rom ( HRC) upgraded at BofA/Merrill from Underperform to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $34 price target.

Johnson & Johnson ( JNJ) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. $74 price target.

McDonald's ( MCD) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $92 price target. Company faces multiple growth headwinds.

Navistar ( NAV) upgraded at JP Morgan from Underweight to Neutral, JP Morgan said. Risk/reward is more balanced at current levels.

Petrologistics ( PDH) rated new Buy at UBS. $16.50 price target. Propylene price dip and stock weakness gives a good buying opportunity.

PetSmart ( PETM) rated new Overweight at Morgan Stanley. $75 price target. Company can deliver stable growth and gain market share.

Power Integrations ( POWI) downgraded at Sterne Agee from Buy to Neutral, Sterne Agee said. Company will likely face weaker customer demand. $43 price target.

UnitedHealth ( UNH) rated new Overweight at JP Morgan. $72 price target. Company remains a core holding, despite industry regulatory risks.

Woodward ( WWD) rated new Buy at Keybanc. $45 price target. Company is leveraged to late-cycle secular growth.

STOCK COMMENTS / EPS CHANGES

Biogen Idec ( BIIB) target raised at Oppenheimer to $145. Analyst day highlights pipeline strength. Outperform rating.

CNO Financial ( CNO) added to Conviction Buy List at Goldman. Company can grow faster than its life insurance peers. Buy rating and $9 price target.

Forest Laboratories ( FRX) estimates cut at Morgan Stanley through 2014, Morgan Stanley said. Company lowered its guidance. $35 price target.

Great Plains Energy ( GXP) added to Top Picks Live! at Citigroup. $23 price target. Valuation gap should narrow as rates come closer to fruition and regulatory concerns diminish.

Hershey ( HSY) added to Conviction Buy List at Goldman. Company can deliver above-average sales and earnings growth. $76 price target.

JPMorgan Chase ( JPM) target lowered at Oppenheimer to $56. Contraction of market multiple. Outperform rating.

Mastercard ( MA) numbers lowered at Jefferies. Shares of MA now seen reaching $507, Jefferies said. Estimates also lowered on FX and macro risks. Buy rating.

Altria ( MO) target raised at Morgan Stanley to $30, according to Morgan Stanley. There's room for industry price increases in the U.S.

Scotts Miracle-Gro ( SMG) numbers cut at BofA/Merrill. Shares of SMG now seen reaching $39, according to Bank of America/Merrill Lynch. Estimates also reduced, given the company's new guidance. Underperform rating.

AT&T ( T) target raised at Jefferies to $36, Jefferies said. Divestiture of Advertising Solutions should help value gap close. Hold rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

More from Stocks

Dow Futures Tank as Trade War Fears Grip Wall Street

Dow Futures Tank as Trade War Fears Grip Wall Street

Why GE's Stock Has Fallen 9% in the Last 30 Days

Why GE's Stock Has Fallen 9% in the Last 30 Days

5 Stock Picks Under $10 for Millennials

5 Stock Picks Under $10 for Millennials

3 Complicated Investing Strategies Millennials Love

3 Complicated Investing Strategies Millennials Love

Tyson Foods CEO: We Aren't Done Making Deals

Tyson Foods CEO: We Aren't Done Making Deals